Skip to content
← Back to this collection

PUBLICATIONS · 29061295

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2017 Dec 23
First author
Borchmann P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2018 Dec 23;390(10114):2744-2745. doi: 10.1016/S0140-6736(17)32343-7.
    note
    Source null
    related pmid
    29061298
    relationship
    Comment in
  2. citation
    Br J Haematol. 2019 May;185(4):758-760. doi: 10.1111/bjh.15602.
    note
    Source null
    related pmid
    30430556
    relationship
    Comment in

Authors and identifiers

  1. name
    Borchmann P
    type
    Author
  2. name
    Goergen H
    type
    Author
  3. name
    Kobe C
    type
    Author
  4. name
    Lohri A
    type
    Author
  5. name
    Greil R
    type
    Author
  6. name
    Eichenauer DA
    type
    Author
  7. name
    Zijlstra JM
    type
    Author
  8. name
    Markova J
    type
    Author
  9. name
    Meissner J
    type
    Author
  10. name
    Feuring-Buske M
    type
    Author
  11. name
    Hüttmann A
    type
    Author
  12. name
    Dierlamm J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Borchmann P
    type
    Author
  2. name
    Goergen H
    type
    Author
  3. name
    Kobe C
    type
    Author
  4. name
    Lohri A
    type
    Author
  5. name
    Greil R
    type
    Author
  6. name
    Eichenauer DA
    type
    Author
  7. name
    Zijlstra JM
    type
    Author
  8. name
    Markova J
    type
    Author
  9. name
    Meissner J
    type
    Author
  10. name
    Feuring-Buske M
    type
    Author
  11. name
    Hüttmann A
    type
    Author
  12. name
    Dierlamm J
    type
    Author
bibliography ids
  1. nci-bib-1f1a0d86b0bca09c6ea90875
book metadata
content sha256
ae01e3b0775a33040e9211ff3e566e0d75dfa8f57416e81886cdf6eb2d43c740
document type
citation
dois
  1. 10.1016/S0140-6736(17)32134-7
electronic publication date
display
2017 Oct 20
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29061295
immutable id
pubmed:29061295@ae01e3b0775a33040e9211ff3e566e0d75dfa8f57416e81886cdf6eb2d43c740
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10114
name
Lancet (London, England)
nlm unique id
2985213R
pages
2790-2802
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2018 Dec 23;390(10114):2744-2745. doi: 10.1016/S0140-6736(17)32343-7.
    note
    Source null
    related pmid
    29061298
    relationship
    Comment in
  2. citation
    Br J Haematol. 2019 May;185(4):758-760. doi: 10.1111/bjh.15602.
    note
    Source null
    related pmid
    30430556
    relationship
    Comment in
outcomes validated
false
pmid
29061295
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
a1ad0303cf305fb26db31e47da02c6cf9fe5eefd7ae2659b0e60bcb532b69014
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec 23
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29061295/
title
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.

Preserved source evidence · Not medical advice